Atu027: Completed Phase Ib/IIa enrollment

Silence said it completed enrollment of 24 patients with locally advanced or metastatic pancreatic adenocarcinoma in the Phase

Read the full 183 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE